Literature DB >> 27647913

Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism.

Sven O Dahms1, Marcelino Arciniega2, Torsten Steinmetzer3, Robert Huber4, Manuel E Than5.   

Abstract

Proprotein convertases (PCs) are highly specific proteases required for the proteolytic modification of many secreted proteins. An unbalanced activity of these enzymes is connected to pathologies like cancer, atherosclerosis, hypercholesterolaemia, and infectious diseases. Novel protein crystallographic structures of the prototypical PC family member furin in different functional states were determined to 1.8-2.0 Å. These, together with biochemical data and modeling by molecular dynamics calculations, suggest essential elements underlying its unusually high substrate specificity. Furin shows a complex activation mechanism and exists in at least four defined states: (i) the "off state," incompatible with substrate binding as seen in the unliganded enzyme; (ii) the active "on state" seen in inhibitor-bound furin; and the respective (iii) calcium-free and (iv) calcium-bound forms. The transition from the off to the on state is triggered by ligand binding at subsites S1 to S4 and appears to underlie the preferential recognition of the four-residue sequence motif of furin. The molecular dynamics simulations of the four structural states reflect the experimental observations in general and provide approximations of the respective stabilities. Ligation by calcium at the PC-specific binding site II influences the active-site geometry and determines the rotamer state of the oxyanion hole-forming Asn295, and thus adds a second level of the activity modulation of furin. The described crystal forms and the observations of different defined functional states may foster the development of new tools and strategies for pharmacological intervention targeting furin.

Entities:  

Keywords:  activation; conformational transition; serine-protease; specificity

Mesh:

Substances:

Year:  2016        PMID: 27647913      PMCID: PMC5056075          DOI: 10.1073/pnas.1613630113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Novel Furin Inhibitors with Potent Anti-infectious Activity.

Authors:  Kornelia Hardes; Gero L Becker; Yinghui Lu; Sven O Dahms; Susanne Köhler; Wolfgang Beyer; Kirsten Sandvig; Hiroyuki Yamamoto; Iris Lindberg; Lisa Walz; Veronika von Messling; Manuel E Than; Wolfgang Garten; Torsten Steinmetzer
Journal:  ChemMedChem       Date:  2015-05-14       Impact factor: 3.466

2.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

3.  Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.

Authors:  T Komiyama; R S Fuller
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

4.  Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.

Authors:  Stefan Henrich; Iris Lindberg; Wolfram Bode; Manuel E Than
Journal:  J Mol Biol       Date:  2005-01-14       Impact factor: 5.469

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Differential global structural changes in the core particle of yeast and mouse proteasome induced by ligand binding.

Authors:  Marcelino Arciniega; Philipp Beck; Oliver F Lange; Michael Groll; Robert Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

7.  Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.

Authors:  Tomoko Komiyama; Julia M Coppola; Martha J Larsen; Marcian E van Dort; Brian D Ross; Robert Day; Alnawaz Rehemtulla; Robert S Fuller
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

8.  The crystal structure of the proprotein processing proteinase furin explains its stringent specificity.

Authors:  Stefan Henrich; Angus Cameron; Gleb P Bourenkov; Reiner Kiefersauer; Robert Huber; Iris Lindberg; Wolfram Bode; Manuel E Than
Journal:  Nat Struct Biol       Date:  2003-07

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  30 in total

1.  Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin.

Authors:  Kornelia Hardes; Teodora Ivanova; Bastian Thaa; Gerald M McInerney; Tove Irene Klokk; Kirsten Sandvig; Sebastian Künzel; Iris Lindberg; Torsten Steinmetzer
Journal:  ChemMedChem       Date:  2017-04-04       Impact factor: 3.466

2.  Specific and Selective Inhibitors of Proprotein Convertases Engineered by Transferring Serpin B8 Reactive-Site and Exosite Determinants of Reactivity to the Serpin α1PDX.

Authors:  Gonzalo Izaguirre; Marcelino Arciniega; Andrea G Quezada
Journal:  Biochemistry       Date:  2019-03-08       Impact factor: 3.162

Review 3.  Proprotein convertase inhibition: Paralyzing the cell's master switches.

Authors:  Andres J Klein-Szanto; Daniel E Bassi
Journal:  Biochem Pharmacol       Date:  2017-04-27       Impact factor: 5.858

4.  Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2.

Authors:  Thanawat Thaingtamtanha; Stephan A Baeurle
Journal:  J Mol Model       Date:  2022-07-19       Impact factor: 2.172

5.  Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin.

Authors:  Monika A Lewandowska-Goch; Anna Kwiatkowska; Teresa Łepek; Kévin Ly; Pauline Navals; Hugo Gagnon; Yves L Dory; Adam Prahl; Robert Day
Journal:  ACS Med Chem Lett       Date:  2021-02-05       Impact factor: 4.345

6.  The interactions of folate with the enzyme furin: a computational study.

Authors:  Zahra Sheybani; Maryam Heydari Dokoohaki; Manica Negahdaripour; Mehdi Dehdashti; Hassan Zolghadr; Mohsen Moghadami; Seyed Masoom Masoompour; Amin Reza Zolghadr
Journal:  RSC Adv       Date:  2021-07-06       Impact factor: 4.036

7.  Dichlorophenylpyridine-Based Molecules Inhibit Furin through an Induced-Fit Mechanism.

Authors:  Sven O Dahms; Gisela Schnapp; Martin Winter; Frank H Büttner; Marco Schlepütz; Christian Gnamm; Alexander Pautsch; Hans Brandstetter
Journal:  ACS Chem Biol       Date:  2022-04-04       Impact factor: 4.634

Review 8.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

Review 9.  Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.

Authors:  Qianqian Zhang; Rong Xiang; Shanshan Huo; Yunjiao Zhou; Shibo Jiang; Qiao Wang; Fei Yu
Journal:  Signal Transduct Target Ther       Date:  2021-06-11

10.  Furin inhibitor protects against neuronal cell death induced by activated NMDA receptors.

Authors:  Mariko Yamada; Hideki Hayashi; Moe Yuuki; Nahoko Matsushima; Bo Yuan; Norio Takagi
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.